Contact Information: CONTACT: Medis Technologies Ltd. Robert K. Lifton Chairman & CEO (212) 935-8484 INVESTOR RELATIONS COUNSEL: The Equity Group Inc. Adam Prior (212) 836-9606 Devin Sullivan (212) 836-9608
Medis Technologies Schedules Third Quarter Financial Results and Conference Call
| Source: Medis Technologies Ltd.
NEW YORK, NY -- (MARKET WIRE) -- November 2, 2006 -- Medis Technologies Ltd. (NASDAQ : MDTL )
("Medis") announced today that it will issue its financial results for the
third quarter ended September 30, 2006 on Thursday, November 9, 2006.
Management will also conduct a conference call that morning at 11:00 a.m.
Eastern Time to discuss these results and the current status of its
business operations.
Interested parties may participate in the call by dialing 866-820-1713
(Domestic) or 706-643-3137 (International) approximately 10 minutes before
the call is scheduled to begin and ask to be connected to the Medis
conference call or conference code #9180114. A recorded replay of the call
will be available until 12:00 a.m. Eastern Time on November 15, 2006.
Listeners may dial 800-642-1687 (Domestic) or 706-645-9291 (International)
and use the code #9180114 for the replay.
The call will also be simultaneously broadcast over the Internet. To
listen to the live webcast, please go to www.medistechnologies.com and
click on the conference call link, or go directly to
http://audioevent.mshow.com/311490/. The conference call will be archived
and accessible for approximately 30 days if you are unable to listen to the
live call.
Medis Technologies' primary focus is on direct liquid fuel cell technology.
Its business strategy is to sell its products to end users through retail
outlets, service providers and to the military and other markets. Medis has
also developed the CellScan with many potential applications relating to
disease diagnostics and chemo sensitivity. Additionally, Medis' product
pipeline includes other technologies, in varying stages of development.
This press release may contain forward-looking statements, which are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. In some cases you can identify those so-called
"forward-looking statements" by words such as "may," "will," "should,"
"expects," "plans," "targets," "believes," "anticipates," "estimates,"
"predicts," "potential," or "continue" or the negative of those words and
other comparable words. These forward-looking statements are subject to
risks and uncertainties, product tests, commercialization risks,
availability of financing and results of financing efforts that could cause
actual results to differ materially from historical results or those
anticipated. Further information regarding these and other risks is
described from time to time in the Company's filings with the SEC. We
assume no obligation to update or alter our forward-looking statements made
in this release or in any periodic report filed by us under the Securities
Exchange Act of 1934 or any other document, whether as a result of new
information, future events or otherwise, except as otherwise required by
applicable federal securities laws.
This press release is available on Medis' web site at
www.medistechnologies.com.